NI201000212A - Dronedarona para la prevención de la cardioversión. - Google Patents

Dronedarona para la prevención de la cardioversión.

Info

Publication number
NI201000212A
NI201000212A NI201000212A NI201000212A NI201000212A NI 201000212 A NI201000212 A NI 201000212A NI 201000212 A NI201000212 A NI 201000212A NI 201000212 A NI201000212 A NI 201000212A NI 201000212 A NI201000212 A NI 201000212A
Authority
NI
Nicaragua
Prior art keywords
dronedarone
cardioversion
prevention
preparation
medicinal product
Prior art date
Application number
NI201000212A
Other languages
English (en)
Inventor
Gaudin Christophe
Hamdani Nacéra
Radzik Davide
Van Eickels Martin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39739955&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201000212(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NI201000212A publication Critical patent/NI201000212A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Furan Compounds (AREA)

Abstract

Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión.
NI201000212A 2008-06-10 2010-12-06 Dronedarona para la prevención de la cardioversión. NI201000212A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6026008P 2008-06-10 2008-06-10
EP08290532A EP2133075A1 (en) 2008-06-10 2008-06-10 Use of dronedarone for the preparation of a medicament intended for the prevention of cardioversion

Publications (1)

Publication Number Publication Date
NI201000212A true NI201000212A (es) 2011-04-27

Family

ID=39739955

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201000212A NI201000212A (es) 2008-06-10 2010-12-06 Dronedarona para la prevención de la cardioversión.

Country Status (25)

Country Link
US (1) US20110166221A1 (es)
EP (2) EP2133075A1 (es)
JP (1) JP2011522875A (es)
KR (1) KR20110026421A (es)
CN (1) CN102056602A (es)
AR (1) AR072070A1 (es)
AU (1) AU2009259008A1 (es)
BR (1) BRPI0915015A2 (es)
CA (1) CA2727210A1 (es)
CL (1) CL2010001421A1 (es)
CO (1) CO6280478A2 (es)
CR (1) CR11755A (es)
DO (1) DOP2010000361A (es)
EA (1) EA201071412A1 (es)
EC (1) ECSP10010661A (es)
IL (1) IL209790A0 (es)
MA (1) MA32461B1 (es)
MX (1) MX2010013700A (es)
NI (1) NI201000212A (es)
PE (1) PE20110066A1 (es)
SV (1) SV2010003753A (es)
TW (1) TW201002314A (es)
UY (1) UY31887A (es)
WO (1) WO2009150534A1 (es)
ZA (1) ZA201009171B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
US8410167B2 (en) 2008-04-17 2013-04-02 Sanofi Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2013024411A1 (en) 2011-08-12 2013-02-21 Lupin Limited Co-milled formulation of dronedarone
CN104721547A (zh) * 2015-03-14 2015-06-24 包汉雨 一种促进房颤患者复律的中药组合物

Also Published As

Publication number Publication date
WO2009150534A1 (en) 2009-12-17
DOP2010000361A (es) 2010-12-31
UY31887A (es) 2010-01-29
MX2010013700A (es) 2011-02-23
EP2303259A1 (en) 2011-04-06
ZA201009171B (en) 2012-03-28
CL2010001421A1 (es) 2011-05-13
BRPI0915015A2 (pt) 2015-10-27
US20110166221A1 (en) 2011-07-07
AR072070A1 (es) 2010-08-04
PE20110066A1 (es) 2011-02-16
ECSP10010661A (es) 2011-01-31
IL209790A0 (en) 2011-02-28
TW201002314A (en) 2010-01-16
CR11755A (es) 2011-01-10
EP2133075A1 (en) 2009-12-16
MA32461B1 (fr) 2011-07-03
JP2011522875A (ja) 2011-08-04
KR20110026421A (ko) 2011-03-15
CO6280478A2 (es) 2011-05-20
CN102056602A (zh) 2011-05-11
SV2010003753A (es) 2011-03-15
AU2009259008A1 (en) 2009-12-17
EA201071412A1 (ru) 2011-06-30
CA2727210A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
NI201000211A (es) Dronedarona para la prevención de la fibrilación auricular permanente.
SV2010003700A (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CL2015000345A1 (es) Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.
CL2012000319A1 (es) Uso de una composición farmaceutica que comprende treprostinil para la preparación de un medicamento para el tratamiento o la prevención de una afección asociada a la fibrosis quística.
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
CL2012003075A1 (es) Composicion farmaceutica en solucion de pazopanib, estable y para uso oftalmico; metodo para la preparacion de dicha solucion.
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
BRPI1010617A2 (pt) uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição.
CO2019008103A2 (es) Composiciones farmacéuticas para terapia de combinación
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI0818459A2 (pt) Composição farmacêutica adequada para uso oftálmico.
SV2011003827A (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
NI201000212A (es) Dronedarona para la prevención de la cardioversión.
CL2014003525A1 (es) Composicion farmaceutica que comprende fimasartan, hidroclorotiazida y un aglutinante; procedimiento de preparacion; su uso en el tratamiento de hipertension.
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
BR112014007022A8 (pt) composição farmacêutica, método de melhoria da absorção no intestino delgado e uso de uma composição farmacêutica.
BR112013010061A2 (pt) "composição farmacêutica, composição e uso"
CR20140526A (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis